[ Tips ] 一分鐘使用導覽
商品編號： UV5641 出版日期： 2011/03/22 作者姓名： Schill, Michael J.;Durick, Brett;Chambers, Drew 商品類別： Finance 商品規格： 16p 再版日期： 2018/11/08 地域： 產業： Biotechnology;Pharmaceuticals 個案年度： -
商品敘述：
This case examines the decision by the Swiss pharmaceutical Roche Holding AG (Roche) to offer a record $42 billion bond in February 2009. In light of a pending acquisition of U.S. biotechnology leader, Genentech, Roche management planned to sell $32 billion in bonds at various maturities from 1 year to 30 years and in three different currencies (U.S. dollar, euro, and British pound). In a context of substantial uncertainty in both world financial markets and the value of the Genentech deal, students are introduced to the pricing of corporate bonds by being invited to price Roche''s bold global offering.
涵蓋領域：
Bonds;Credit;Debt management;Finance;Health care policy
相關資料：
Case Teaching Note, (UV5642), 10p, by Michael J. Schill;Spreadsheet Supplement, (UV5644), 0p, by Michael J. Schill
哪些人也有訂購？